Is Tirzepatide the same as semaglutide?

No. Semaglutide is a GLP-1 receptor agonist only. Tirzepatide is a dual GLP-1/GIP receptor agonist. The addition of GIP agonism is responsible for Tirzepatide's superior efficacy and tolerability.

What is the difference between Mounjaro and Zepbound?

Mounjaro and Zepbound are both tirzepatide — same molecule, same doses. Mounjaro is FDA-approved for T2DM; Zepbound is FDA-approved for chronic weight management. The commercial formulations are identical.

What is the difference between Ozempic and Wegovy?

Both are semaglutide. Ozempic is FDA-approved for T2DM at doses up to 2mg weekly. Wegovy is FDA-approved for chronic weight management at 2.4mg weekly — a higher maximum dose.

Can I switch from Wegovy to Zepbound?

Yes, switching is common in clinical practice. A washout period is not required. Titration should start at Zepbound 2.5mg and increase gradually. Consult a licensed prescriber.

How much does Tirzepatide cost vs semaglutide?

List price: Zepbound ~$1,060/month, Wegovy ~$1,350/month. With insurance or manufacturer coupons, costs vary significantly. Compounded alternatives are substantially cheaper for research.

Is compounded tirzepatide or semaglutide legal?

During active FDA drug shortages, licensed compounding pharmacies may produce compounded versions legally under Section 503A/503B of the FDCA. Legal status depends on current shortage designation.

Do Wegovy and Zepbound cause the same side effects?

Both cause nausea, vomiting, diarrhea, and constipation — class GLP-1 effects. Tirzepatide tends to have lower nausea rates due to GIP's protective effect on the GI tract. Both can cause rare thyroid C-cell tumors (black box warning).

Tirzepatide vs Semaglutide: Dosing, Half-Life, Side Effects + Which to Choose (2026) | PeptiDex

Quick Verdict

Zepbound (Tirzepatide) outperforms Wegovy (Semaglutide) on weight loss (~20% vs ~15% body weight) due to dual GLP-1/GIP mechanism. Both are FDA-approved. Tirzepatide is often better tolerated. Choose Wegovy first for established safety profile; upgrade to Zepbound for maximum efficacy.

Side-by-Side Analysis

Dimension	Tirzepatide	Semaglutide
Mechanism	Dual receptor agonism at GLP-1 and GIP receptors for synergistic appetite suppression, improved insulin sensitivity, and enhanced metabolic function.	GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection.
Primary Benefits	Weight loss, body recomposition, glycemic control	Fat loss, appetite control, cardiovascular benefits
Typical Dose	2500–2500mcg	250–250mcg
Route	SubQ	SubQ
Frequency	1x/wk	1x/wk
Half-Life	120 hours	168 hours
FDA Status	Approved	Approved
Evidence Grade	very-strong	very-strong
Key Studies	20+ indexed	20+ indexed
Lowest Price	$69.99 / 5mg via Amino Club	$47.99 / 5mg via Amino Club

Which one should you choose?

Tirzepatide (Zepbound) produces greater weight loss (~20% vs ~15% for Wegovy) due to its dual GLP-1/GIP agonism. Wegovy remains a highly effective, slightly more affordable alternative with a longer safety track record. Both require a prescription in branded form. For research use, compounded semaglutide and compounded tirzepatide are available from licensed compounders. Choose Wegovy/semaglutide as an established starting point. Choose Zepbound/tirzepatide to maximize efficacy or if Wegovy side effects are limiting.

Who Should Choose Tirzepatide?

Choose Tirzepatide (Zepbound/Mounjaro) if:

Maximum weight loss efficacy is the priority
You've plateaued on semaglutide
GI side effects of Wegovy have been intolerable (Tirzepatide often gentler)
You have comorbid T2DM (Mounjaro is approved for glycemic control)

Who Should Choose Semaglutide?

Choose Semaglutide (Wegovy/Ozempic) if:

You want the most established long-term safety data (SUSTAIN, STEP trials)
Cost is a major consideration (Wegovy may have more insurance coverage)
You are starting a GLP-1 protocol for the first time
Once-weekly injection is the primary convenience driver

Can you stack Tirzepatide + Semaglutide?

Never stack Tirzepatide and Semaglutide — they share the GLP-1 receptor. Stacking creates dangerous additive GLP-1 stimulation risk: severe nausea, hypoglycemia, and cardiovascular complications. They are mechanistic competitors, not complements.

Vendor Pricing

· Affiliate links · Prices verified 2026

Tirzepatide

2 vendors

Amino Club Best Value

5mg vial · $14.00/mg

$69.99Buy

Limitless Life

5mg vial · $16.00/mg

$80.00Buy

Full vendor comparison for Tirzepatide

Semaglutide

2 vendors

Amino Club Best Value

5mg vial · $9.60/mg

$47.99Buy

Limitless Life

5mg vial · $11.60/mg

$58.00Buy

Full vendor comparison for Semaglutide

Affiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.

Frequently Asked Questions

The SURMOUNT-1 trial showed Tirzepatide (Zepbound) achieved ~20% body weight loss vs Wegovy's ~15% in the STEP 1 trial. Head-to-head trials (SURPASS-CVOT) confirm Tirzepatide's superior efficacy.

Related Comparisons

Weight Loss

Semaglutide vs Tirzepatide

Read comparison

Advanced

Tirzepatide vs Retatrutide

Read comparison

Progression

Semaglutide vs Retatrutide

Read comparison

Deep Dive Profiles

Tirzepatide Research Profile Semaglutide Research Profile

Research Tools

PK Plasma Curves

Visualize Tirzepatide & Semaglutide plasma concentration over time

Reconstitution Calculator

Calculate precise dilution volumes and concentrations

Research Use Only — Not Medical Advice

This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.